Alendronate loaded graphene oxide functionalized collagen sponge for the dual effects of osteogenesis and anti-osteoclastogenesis in osteoporotic rats
作者机构:Department of Plastic SurgeryUnion HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhan430022China Wuhan Clinical Research Center for Superficial Organ ReconstructionWuhan430022China
出 版 物:《Bioactive Materials》 (生物活性材料(英文))
年 卷 期:2020年第5卷第4期
页 面:859-870页
核心收录:
学科分类:081702[工学-化学工艺] 1002[医学-临床医学] 100210[医学-外科学(含:普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 08[工学] 0817[工学-化学工程与技术] 10[医学]
基 金:supported by the National Key R&D Program of China(2019YFA0110500) the National Natural Science Foundation of China(81701922,81873941)
主 题:Osteoporosis Osteoporotic bone defect Graphene oxide Osteoclast Alendronate
摘 要:Graphene Oxide(GO)-related hydrogels have been extensively studied in hard tissue repair,because GO can not only enhance the mechanical properties of polymers but also promote osteogenic differentiation of mesenchymal stem ***,simple GO-related hydrogels are not ideal for the repair of osteoporotic bone defects as the overactive osteoclasts in ***(Aln)is known to inhibit osteoclasts and may bind to GO through covalent ***,delivering Aln in GO-related hydrogels may be effective to repair osteoporotic bone ***,we developed a control-released system which is constructed by collagen(Col)-GO sponges loaded with Aln(Col-GO-Aln)for osteoporotic bone defect *** vitro,Col-GO-Aln sponges prolonged the release period of Aln,and the sponge containing 0.05%(w/v)GO released Aln faster than sponge with 0.2%***,tartrate-resistant acid phosphatase(TRAP)and F-actin staining demonstrated that Col-GO-Aln sponges effectively inhibited osteoclastogenesis of *** vivo,micro-CT scan showed that the volume of newborn bone in defect site by 0.05%GO sponge was nearly three times larger than that of other ***,the CT and histological examinations of rat femur proved that Col-GO-Aln sponges decreased the number of osteoclasts and suppressed the systemic bone loss in osteoporotic *** findings reveal that the application of GO as carriers of anti-osteoporosis drugs is a viable treatment for *** results also underscore the potential of GO-related hydrogels with Aln-releasing capacity for bone regeneration in osteoporosis.